Publications by authors named "Andrew D Kelly"

11Publications

Genomic and epigenomic predictors of response to guadecitabine in relapsed/refractory acute myelogenous leukemia.

Clin Epigenetics 2019 07 22;11(1):106. Epub 2019 Jul 22.

Fels Institute for Cancer Research and Molecular Biology, Temple University School of Medicine, Philadelphia, PA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13148-019-0704-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6647096PMC
July 2019

TET1-Mediated Hypomethylation Activates Oncogenic Signaling in Triple-Negative Breast Cancer.

Cancer Res 2018 08 11;78(15):4126-4137. Epub 2018 Jun 11.

Fels Institute for Cancer Research and Molecular Biology, Lewis Katz School of Medicine at Temple University, Philadelphia, Pennsylvania.

View Article

Download full-text PDF

Source
http://cancerres.aacrjournals.org/lookup/doi/10.1158/0008-54
Publisher Site
http://dx.doi.org/10.1158/0008-5472.CAN-17-2082DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6072603PMC
August 2018

Demethylator phenotypes in acute myeloid leukemia.

Leukemia 2018 10 7;32(10):2178-2188. Epub 2018 Mar 7.

Fels Institute for Cancer Research and Molecular Biology, Lewis Katz School of Medicine at Temple University, Philadelphia, PA, 19140, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41375-018-0084-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6128790PMC
October 2018

Epigenetics and Precision Oncology.

Cancer J 2017 Sep/Oct;23(5):262-269

From the *Fels Institute for Cancer Research and Molecular Biology, Lewis Katz School of Medicine at Temple University, Philadelphia, PA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PPO.0000000000000281DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5708865PMC
May 2018

The promise of epigenetic therapy: reprogramming the cancer epigenome.

Curr Opin Genet Dev 2017 Feb 14;42:68-77. Epub 2017 Apr 14.

Fels Institute for Cancer Research and Molecular Biology, Lewis Katz School of Medicine at Temple University, Philadelphia, PA 19140, USA. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S0959437X173003
Publisher Site
http://dx.doi.org/10.1016/j.gde.2017.03.015DOI Listing
February 2017

MicroRNA-155 expression is independently predictive of outcome in chordoma.

Oncotarget 2015 Apr;6(11):9125-39

Sarcoma Biology Laboratory, Department of Orthopaedic Surgery, Massachusetts General Hospital, Boston, MA 02114, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4496207PMC
http://dx.doi.org/10.18632/oncotarget.3273DOI Listing
April 2015

Next-generation sequencing and microarray-based interrogation of microRNAs from formalin-fixed, paraffin-embedded tissue: preliminary assessment of cross-platform concordance.

Genomics 2013 Jul 3;102(1):8-14. Epub 2013 Apr 3.

Division of Hematology/Oncology, Sarcoma Program, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, 330 Brookline Avenue, Boston, MA 02215, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygeno.2013.03.008DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4116671PMC
July 2013

Metabolomic profiling from formalin-fixed, paraffin-embedded tumor tissue using targeted LC/MS/MS: application in sarcoma.

PLoS One 2011 3;6(10):e25357. Epub 2011 Oct 3.

Division of Hematology/Oncology, Sarcoma Program, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0025357PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3184969PMC
January 2012